Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
- First Posted Date
- 2018-12-11
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT03771820
- Locations
- 🇨🇿
0701, Brno, Czechia
🇨🇳0404, Taichung City, Taiwan
🇷🇺0801, Ekaterinburg, Russian Federation
Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT03168035
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT03168061
- Locations
- 🇺🇸
Comprehensive Cancer Centers of Nevada - USOR, Las Vegas, Nevada, United States
🇺🇸City of Hope National Medical Center, Duarte, California, United States
🇺🇸University of California Los Angeles, Santa Monica, California, United States
NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Interventions
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 1
- Registration Number
- NCT03109158
- Locations
- 🇧🇬
Complex Oncology Center - Shumen EOOD, Shumen, Bulgaria
ðŸ‡ðŸ‡ºSzabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, NyÃregyháza, Hungary
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 119
- Registration Number
- NCT02240238
- Locations
- 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸University Hospitals Case Medical Center, Cleveland, Ohio, United States
🇺🇸University of Texas Southwestern Medical Center, Dallas, Texas, United States
NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia
- Conditions
- Interventions
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00910741
- Locations
- 🇸🇬
National Cancer Centre Singapore, Singapore 169610, Singapore
🇨🇳Natinal Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan